Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Refractory coronary artery spasm.

V S Bamrah, G J Schuchard

    Journal of the American College of Cardiology
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Ergonovine testing in post-myocardial infarction patients can trigger severe coronary artery spasm and new infarction. Withholding beta-blockers before ergonovine testing is advised.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sequential monotherapy of hypertension.

    Journal of clinical pharmacology·1994
    Same author

    Detection of chronic coronary artery disease: value of pharmacologically stressed, dynamically enhanced turbo-fast low-angle shot MR images.

    AJR. American journal of roentgenology·1993
    Same author

    Diagnostic accuracy of seismocardiography compared with electrocardiography for the anatomic and physiologic diagnosis of coronary artery disease during exercise testing.

    The American journal of cardiology·1993
    Same author

    Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.

    Clinical cardiology·1992
    Same author

    Static versus dynamic exercise: effects on Doppler echocardiographic indices of left ventricular performance.

    Clinical cardiology·1991
    Same author

    Cardiovascular ochronosis: a case report and review of the medical literature.

    Cardiology·1990
    Same journal

    Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial.

    Journal of the American College of Cardiology·2026
    Same journal

    Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry.

    Journal of the American College of Cardiology·2026
    Same journal

    Preparing for Tomorrow, Today: Identifying Predictors of Future Cardiac Complications in Patients With Mild Hypertrophic Cardiomyopathy.

    Journal of the American College of Cardiology·2026
    Same journal

    Environment and the Heart: Measuring the Health Impact of Environmental Risks and Making It Matter.

    Journal of the American College of Cardiology·2026
    Same journal

    Soft Timing, Hard Thresholds, and Myocardial Injury Reclassification With hs-cTnT-gen6.

    Journal of the American College of Cardiology·2026
    Same journal

    High-Sensitivity Cardiac Troponin T-gen 6 Assay and Analytical Imprecision Still a Concern for the Derived Deltas.

    Journal of the American College of Cardiology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Vascular Medicine
    • Pharmacology

    Background:

    • Recurrent angina after myocardial infarction (MI) necessitates thorough investigation.
    • Ergonovine testing is used to diagnose coronary artery spasm but carries risks.

    Observation:

    • A patient presenting with refractory myocardial ischemia underwent cardiac catheterization post-MI.
    • Severe proximal right coronary artery spasm was induced by ergonovine, partially responsive to medical management.
    • Despite partial spasm relief, persistent ischemia led to a new inferior wall infarction.

    Findings:

    • Ergonovine-induced coronary artery spasm can lead to refractory ischemia and further myocardial infarction, even with medical intervention.
    • The mechanism of persistent ischemia despite partial spasm relief warrants further investigation.

    Related Experiment Videos

    Implications:

    • Ergonovine testing may pose significant risks during the early post-MI period and should be approached with caution.
    • Withholding beta-adrenergic blocking agents prior to anticipated ergonovine testing is recommended to mitigate potential adverse events.